Clinical Monitoring and Early Intervention

Treatment for Dengue

Typical Dosage: Daily clinical assessment including vital signs, fluid intake/output, hematocrit, platelet count

Effectiveness
92%
Safety Score
95%
Clinical Trials
100
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Daily clinical assessment including vital signs, fluid intake/output, hematocrit, platelet count
Time to Effect
Ongoing throughout critical phase (3-7 days after symptom onset)
Treatment Duration
3-7 days
Evidence Quality
HIGH
Number Needed to Treat (NNT)
10(Treat 10 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$555.56
Clinical Monitoring and Early Intervention Outcomes

for Dengue

Efficacy Outcomes
Overall Effectiveness
+92%
Response Rate
+90%
Common Side Effects
Patient anxiety
+2%

Sources:

researchgate.net
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov